Abcam Plc Company Profile (LON:ABC)

Analyst Ratings

Consensus Ratings for Abcam Plc (LON:ABC) (?)
Ratings Breakdown: 5 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: GBX 626.60

Analysts' Ratings History for Abcam Plc (LON:ABC)
Show:
DateFirmActionRatingPrice TargetActions
7/26/2016JPMorgan Chase & Co.Reiterated RatingNeutralGBX 581View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2016Numis Securities LtdReiterated RatingAddGBX 850View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2016Stifel NicolausReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/4/2016Royal Bank Of CanadaInitiated CoverageSector PerformerGBX 610View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2016Peel HuntReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Canaccord GenuityUpgradeHoldGBX 432View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2015InvestecReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2015FinnCapReiterated RatingUnder ReviewView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015N+1 SingerReiterated RatingSellGBX 411View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Abcam Plc (LON:ABC)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Abcam Plc (LON:ABC)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Abcam Plc (LON:ABC)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
3/7/2016GBX 2.350.38%3/17/20163/17/20164/15/2016Tweet This Announcement  Share This Announcement on StockTwits
9/14/2015GBX 5.920.99%11/12/201511/12/201512/4/2015Tweet This Announcement  Share This Announcement on StockTwits
9/9/2014GBX 5.621.31%11/6/201411/6/201411/28/2014Tweet This Announcement  Share This Announcement on StockTwits
3/4/2014GBX 2.130.5%3/19/20143/19/20144/18/2014Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Abcam Plc (LON:ABC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
11/11/2015Hirzel,Alan ThomasInsiderBuy3,335GBX 580£19,343Tweet This Trade  Share This Trade on StockTwits
10/27/2015Iliffe,JeffreyInsiderBuy301GBX 599£1,802.99Tweet This Trade  Share This Trade on StockTwits
9/18/2015Hirzel,Alan ThomasInsiderBuy4,000GBX 615£24,600Tweet This Trade  Share This Trade on StockTwits
3/26/2015Jonathan Simon MilnerInsiderSell2,480,000GBX 465£11,532,000Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Abcam Plc (LON:ABC)
DateHeadline
07/25/16 07:00 AMAbcam : Annual Revenue Grows On Strong Product Portfolio Performances
07/25/16 01:28 AMPre-Close Period Update - [at noodls] - 25 July 2016 ABCAM PLC ('Abcam' or 'the Company') Delivering close to 16% sales growth, whilst investing for the future Cambridge UK: Abcam plc (AIM: ABC), a global leader in the supply of life science ...
07/14/16 11:03 AMMarket Forecast Report on Antibodies 2016-2026
07/07/16 10:13 AMBoys make history with ‘overclocking’
07/06/16 02:18 PMResearch Offers 10-Year Forecast on Antibodies Market
07/05/16 02:12 PMNm23H1 mediates tumor invasion in esophageal squamous cell carcinoma by regulation of CLDN1 through the AKT signaling
06/29/16 10:07 AM£12m fundraise as Cambridge Uni spin-out whips up a storm
06/22/16 07:24 PMGlobal Oxidative Stress Assay Market to Benefit from Growth in Pharmaceutical Industry
06/22/16 07:24 PMAbcam : Webinar Addresses Raising Antibody Validation Standards with Knockout Technology
06/20/16 01:09 AMAbcam to appoint Gavin Wood as CFO - [at noodls] - 20 June 2016 ABCAM PLC Abcam to appoint Gavin Wood, former Affymetrix executive, as Chief Financial Officer Cambridge, UK: Abcam plc(AIM: ABC) ('Abcam'), a global leader in the supply of life science research ...
06/17/16 02:05 PMGlobal metabolomics industry consumption forecast to 2021 detailed in new research report
05/23/16 02:00 PMDefiniGEN raises £1.5M in follow-on funding - Dr Jonathan Milner, Chairman of DefiniGEN and formerly CEO of Abcam Plc, said: “DefiniGEN is harnessing the power of stem cell technology to develop products that are transformational for drug discovery, enabling the accelerated development of therapies ...
05/18/16 12:29 PMAbcam (LON:ABC) Broker Updates - Share Trading News - Abcam (LON:ABC) Broker UpdatesShare Trading NewsAbcam plc is engaged in producing and marketing protein research tools. The Company offers products, such as primary antibodies, including monoclonals, polyclonals, conjugated primary antibodies, tags and cell markers, loading controls, flow cytometry ...and more »
05/13/16 06:16 AMBeaufort Securities Breakfast Alert: Eurasia Mining, Jubilee Paltinum, Savannah Resources, Caledonia Mining ... - Proactive Investors UK - Beaufort Securities Breakfast Alert: Eurasia Mining, Jubilee Paltinum, Savannah Resources, Caledonia Mining ...Proactive Investors UKThe meeting also adopted new charter documents and changed its name to Caledonia Mining Corporation plc. ... New marketing channels were established through partnerships with leading organisations such as ThermoFisher and Abcam. During the year ...and more »
05/10/16 03:36 AMAbcam Plc breached its 50 day moving average in a Bullish Manner : ABC-GB : May 10, 2016 -
05/05/16 06:06 AMNew Immunoassay Research Suite Enables Faster Drug and Biomarker Discovery - Labmate Online - Labmate OnlineNew Immunoassay Research Suite Enables Faster Drug and Biomarker DiscoveryLabmate OnlineAbcam plc have announced the launch of a suite of immunoassay products based on its recombinant, monoclonal antibody pairs, as part of its commitment to deliver quality reagents to life science researchers at scale. Matched antibody pairs are central ...
05/05/16 06:06 AMAbcam (LON:ABC) Morning Trade Volumes - Share Trading News - Share Trading NewsAbcam (LON:ABC) Morning Trade VolumesShare Trading NewsAbcam plc is engaged in producing and marketing protein research tools. The Company offers products, such as primary antibodies, including monoclonals, polyclonals, conjugated primary antibodies, tags and cell markers, loading controls, flow cytometry ...and more »
05/04/16 05:12 AMAbcam (LON:ABC) Broker Price Targets - Share Trading News - Abcam (LON:ABC) Broker Price TargetsShare Trading NewsAbcam plc is engaged in producing and marketing protein research tools. The Company offers products, such as primary antibodies, including monoclonals, polyclonals, conjugated primary antibodies, tags and cell markers, loading controls, flow cytometry ...and more »
05/04/16 05:12 AMNew Immunoassay Research Suite Enables Faster Drug and Biomarker Discovery - Abcam plc have announced the launch of a suite of immunoassay products based on its recombinant, monoclonal antibody pairs, as part of its commitment to deliver quality reagents to life science researchers at scale. Matched antibody pairs are central to ...
05/03/16 05:52 AMOxidative Stress Assay Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2023 - Some of the key players in the oxidative stress assay marketbased on pharmaceutical and biotechnological companies are Abcam Plc., BioVision, Inc., Cell Biolabs, Inc., Merck and Co., Inc., Oxford Biomedical Research, Promega Corporation,Sigma-Aldrich ...
05/02/16 05:54 AMAbcam enables faster drug and biomarker discovery with immunoassay research suite - The Scientist - Abcam enables faster drug and biomarker discovery with immunoassay research suiteThe ScientistAbcam plc, a global leader in the supply of life science research tools, today announced the launch of a suite of immunoassay products based on its recombinant, monoclonal antibody pairs, as part of its commitment to deliver quality reagents to life ...
05/02/16 05:54 AMAbcam enables faster drug and biomarker discovery with immunoassay research suite - Abcam plc, a global leader in the supply of life science research tools, today announced the launch of a suite of immunoassay products based on its recombinant, monoclonal antibody pairs, as part of its commitment to deliver quality reagents to life ...
04/28/16 06:04 AMWere Analysts Bearish Abcam Plc (LON:ABC) This Week? - B.O.D.Y Confidential - Were Analysts Bearish Abcam Plc (LON:ABC) This Week?B.O.D.Y ConfidentialOut of 8 analysts covering Abcam PLC (LON:ABC), 3 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 38% are positive. Abcam PLC has been the topic of 24 analyst reports since July 23, 2015 according to StockzIntelligence Inc. Below is a list of ...and more »
04/27/16 06:54 AMFast-growing Horizon Discovery tops expectations - Proactive Investors USA & Canada - Proactive Investors USA & CanadaFast-growing Horizon Discovery tops expectationsProactive Investors USA & CanadaGene editing specialist Horizon Discovery Group PLC (LON:HZD) saw strong growth in revenues and a lower than expected loss in 2015. Total group revenues in 2015 rose 69% to £20.2mln from £11.9mln in 2014, with product revenues up 124% to £7.8mln ...and more »
04/27/16 06:54 AMBeaufort Securities Breakfast Alert: Keras Resources, BooHoo.com, BP, British American Tobacco, Horizon Discovery ... - Proactive Investors UK - Beaufort Securities Breakfast Alert: Keras Resources, BooHoo.com, BP, British American Tobacco, Horizon Discovery ...Proactive Investors UKNew marketing channels were established through partnerships with leading organisations such as ThermoFisher and Abcam. During the year, the company grew in strength on the core capabilities front and expanded its catalogue of products to over 23,000.
04/27/16 06:54 AMFast-growing Horizon Discovery tops expectations - Gene editing specialist Horizon Discovery Group PLC (LON:HZD) saw strong growth in revenues and ... with partnerships with leading organisations such as ThermoFisher and Abcam for our cell lines and through an increasing number of OEM [original equipment ...
04/26/16 06:33 AMHorizon Discovery chief expects year of consolidation after acquisitive 2015 - Proactive Investors UK - Proactive Investors UKHorizon Discovery chief expects year of consolidation after acquisitive 2015Proactive Investors UKDarrin Disley, chief executive of Horizon Discovery Group PLC (LON:HZD), expects to grow strongly again in 2016 after it saw revenues grow 69%, EBITDA come in ahead of expectations, and the company expand its catalogue of products to more than 23,000 ...Fast-growing Horizon Discovery tops expectationsProactive Investors USA & Canadaall 9 news articles »
04/26/16 06:33 AMHorizon Discovery : Investor Relations Update from Horizon Discovery Group plc - Horizon Discovery Group plc (LSE: HZD) ("Horizon"), is a world-leading gene editing ... Definigen), market access (e.g. ThermoFisher, Abcam), and research biotech (e.g. Servier, Redx). Strengthening our infrastructure Horizon employs approximately 230 ...
04/26/16 06:33 AMHorizon Discovery chief expects year of consolidation after acquisitive 2015 - Additionally, deals with Abcam and ThermoFisher have widened the company’s supply ... Meet Central Asia Metals Ltd, Berkeley Energia Ltd, Ariana Resources plc, Highlands Natural Resources Plc and Jubilee Platinum PLC at our event, London, 28 April ...
04/25/16 06:26 AMAvacta : Half-year Report - Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics ... Dr Philippe Cotrel, ex-Commercial Operations Director at Abcam, appointed as Chief Commercial Officer. · Mr Tony Gardiner, ex-Finance Director at AHR, appointed as Chief Financial ...
04/25/16 06:26 AMAbcam Plc (ABC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Report Available - (live-PR.com) - Abcam plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. It develops and markets antibodies and other related products. Its wide range ...
04/15/16 09:52 AMAntibodies Market, 2016-2026 by Segmentation: Based on Product, Based on Application and Region - Antibodies Market: Key Players Some of the key players in global antibodies market are Sigma-Aldrich Corporation, Roche Ltd., Abcam plc, Sanofi S.A., Rockland Immunochemicals, AbbVie Inc., Amgen Inc., Thermo Fisher Scientific Inc., Novartis AG, Biogen-Idec ...
04/13/16 12:00 PMJPMorgan Chase & Co. Reaffirms Neutral Rating for Abcam Plc (ABC) - Washington News Wire - Share Trading NewsJPMorgan Chase & Co. Reaffirms Neutral Rating for Abcam Plc (ABC)Washington News WireAbcam Plc logo JPMorgan Chase & Co. reaffirmed their neutral rating on shares of Abcam Plc (LON:ABC) in a research report sent to investors on Friday morning, AnalystRatings.NET reports. JPMorgan Chase & Co. currently has a GBX 581 ($8.30) price ...JPMorgan Chase & Co. Reiterates "Neutral" Rating for Abcam Plc (ABC)Web Breaking Newsall 1,767 news articles »
04/11/16 12:52 PMHow Many Abcam Plc (LON:ABC)'s Analysts Are Bullish? - RiversideGazette.com - Franklin IndependentHow Many Abcam Plc (LON:ABC)'s Analysts Are Bullish?RiversideGazette.comOut of 8 analysts covering Abcam PLC (LON:ABC), 3 rate it “Buy”, 0 “Sell”, while 5 “Hold”. This means 38% are positive. Abcam PLC was the topic in 24 analyst reports since July 23, 2015 according to StockzIntelligence Inc. Below is a list of Abcam Plc ...Abcam Plc's (ABC) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co.The Vista VoiceAbcam Plc 5.8% Potential Decrease Indicated by JP Morgan CazenoveDirectorsTalk InterviewsAbcam Plc's (ABC) Neutral Rating Reaffirmed at JPMorgan Chase & Co.Mas Market NewsFranklin Independentall 1,901 news articles »
04/11/16 12:52 PMAntofagasta plc (LON:ANTO) Given Average Rating of "Hold" by Brokerages - ... shares which are now outstanding with shareholders and have a price of 1531.11 bringing Victrex PLC's market capitalisation to 1.30B GBP. Abcam Plc LON:ABC has a 50 day moving average of 628.88 GBX and the 200 Day Moving Average price is recorded at ...
04/09/16 09:14 AMAbcam PLC (LON:ABC) Issued With 'Neutral' Rating At JP Morgan Cazenove - FTSE News - Abcam PLC (LON:ABC) Issued With 'Neutral' Rating At JP Morgan CazenoveFTSE NewsOn Thursday JP Morgan Cazenove retained its target for shares of Abcam PLC as 'Neutral' recommending a target price of 581 for investors; potentially meaning there is a decrease of -5.38% from Abcam PLC's share price of 614.02. Abcam PLC has ...and more »
04/09/16 09:14 AMAbcam PLC maintained as Neutral By JP Morgan - Risers & Fallers - Abcam PLC maintained as Neutral By JP MorganRisers & FallersIn an analyst rating update on Friday shares of Abcam PLC (LON:ABC) had their rating maintained by analysts at JP Morgan. The broker said it has now set a 'Neutral' rating on shares of Abcam PLC with a price target of 581. The price target according to ...JP Morgan Maintained Abcam PLC (LON:ABC) As 'Neutral'Share Trading Newsall 2 news articles »
04/09/16 09:14 AMAmino Technologies Plc (AMO) To Go Ex-Dividend on April 7th - The stock's market cap is GBX 2.82 billion. GBX 4930 is the highest target while GBX 3165 is the lowest. Abcam Plc with EPIC/TICKER LON:ABC had its stock rating noted as "Retains" with the recommendation being set at "NEUTRAL" today by analysts at JP ...
04/08/16 09:46 AMAbcam Plc 5.8% Potential Decrease Indicated by JP Morgan Cazenove - DirectorsTalk Interviews - Franklin IndependentAbcam Plc 5.8% Potential Decrease Indicated by JP Morgan CazenoveDirectorsTalk InterviewsAbcam Plc with EPIC/TICKER LON:ABC had its stock rating noted as 'Retains' with the recommendation being set at 'NEUTRAL' today by analysts at JP Morgan Cazenove. Abcam Plc are listed in the Health Care sector within AIM. JP Morgan Cazenove have ...Abcam Plc's (ABC) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co.The Vista VoiceAbcam PLC maintained as Neutral By JP MorganRisers & FallersJP Morgan Maintained Abcam PLC (LON:ABC) As 'Neutral'Share Trading NewsFranklin Independentall 1,077 news articles »
04/08/16 09:46 AMJefferies International Gives Glencore PLC Price Target With Potential -7.21% Downside - ... of 1150 indicating a potential increase of 63.12% from Maintel Holdings PLC's current price of 705. On Friday JP Morgan Cazenove retained its rating on shares of Abcam PLC as "Neutral" issuing a recommended target price of 581 potentially meaning ...
03/08/16 03:36 AMAbcam Plc breached its 50 day moving average in a Bearish Manner : ABC-GB : March 8, 2016 -
03/07/16 09:23 AMAbcam shares sink on news of lower earnings -
03/07/16 06:07 AMHalf Year 2016 Abcam PLC Earnings Release - Time Not Supplied -
02/18/16 03:30 AMAbcam Plc breached its 50 day moving average in a Bullish Manner : February 18, 2016 -
01/21/16 03:31 AMAbcam Plc breached its 50 day moving average in a Bearish Manner : January 21, 2016 -
12/02/15 03:32 AMAbcam Plc breached its 50 day moving average in a Bullish Manner : December 2, 2015 -
11/20/15 01:03 PMAbcam Plc – Value Analysis (LONDON:ABC) : November 20, 2015 -
10/06/15 05:12 AMAbcam’s New Anti-PD-L1 Antibody Enables Deeper Insights into Cancer Immunology Research -
09/09/15 05:55 AMHZD & Abcam plc Sign License & Supply Agreement - [at noodls] - RNS Number : 4689Y Horizon Discovery Group plc 09 September 2015 Horizon Discovery Group plc and Abcam plc Sign License and Supply Agreement · Horizon to exclusively out-license existing human diploid ...
09/09/15 01:12 AMHorizon Discovery Group plc and Abcam plc Sign License and Supply Agreement - [at noodls] - 09/09/2015 Horizon to exclusively out-license existing human diploid and haploid cell line collection for use in validating the function of Abcam antibodies Horizon to receive exclusivity payments totaling ...

Social

About Abcam Plc

Abcam Plc logoAbcam plc is engaged in producing and marketing protein research tools. The Company offers products, such as primary antibodies, including monoclonals, polyclonals, conjugated primary antibodies, tags and cell markers, loading controls, flow cytometry antibodies and others; secondary antibodies, such as Alexa Fluor conjugated secondaries, alkaline phosphatase (AP), horseradish peroxidase (HRP), Biotin and others; immunoassay kits and reagents, such as lateral flow and dipstick assays, antibody arrays and others; cell and tissue imaging tools, such as fluorescent cell imaging and immunohistochemistry (IHC); cellular and biochemical assays, such as cell signaling, and cell damage and oxidative stress, and others; proteins and peptides, such as enzymes, signaling proteins and others; proteomics tools, cellular fractionation and others; lysates, such as cytoplasmic, membrane and others; multiplex micro ribonucleic acid (miRNA) assays, and agonists, activators, antagonists and inhibitors.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: ABC
  • CUSIP:
Key Metrics:
  • Previous Close: $10.22
  • 50 Day Moving Average: $715.57
  • 200 Day Moving Average: $643.62
  • P/E Ratio: 42.27
  • P/E Growth: 0.00
  • Market Cap: $1.53B
  • Current Year EPS Consensus Estimate: $60.67 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: